Kline & Co.

Study: Generic drug makers taking more aggressive approach

Published in Biotech Law Weekly, September 2nd, 2005

With the high cost of prescription medications already a contentious issue, drug manufacturers are now facing an escalated threat from generic drug competitors.

Some of these generics companies are actively contesting the patents of the major research-based firms, and a newly proposed study by Kline & Co. is set to examine the leaders in this movement.

"In the past, the generics companies just used to wait for the patents on brand-name drugs to expire, but now they're being a lot more aggressive and proactive," said Laura Mahecha, healthcare industry manager for Kline's research division. "They're bringing legal challenges to try to break patents in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly

Source: Biotech Law Weekly (2005-09-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry